References
- van Doorn PA, Ruts L, Jacobs BC. Clinical features, pathogenesis, and treatment of Guillain–Barré syndrome. Lancet Neurol. 2008;7:939–950
- Chhibber V, Weinstein R. Evidence based review of therapeutic plasma exchange in neurological disorders. Semin Dial. 2012;25:132–139
- The Guillain–Barré study group. Plasmapheresis and Acute Guillain–Barré syndrome. Neurology. 1985;35:1096–1104
- Winer JB, Hughes RAC, Greenwood RJ, Perkin GD, Healy MJR. Prognosis in Guillain–Barré syndrome. Lancet. 1985;1(8439):1202–1203
- Hughes RAC, Newsom-Davis JM, Perkin GD, Pierce JM. Controlled trial prednisolone in acute polyneuropathy. Lancet. 1978;2(8093):750–753
- Guillain–Barré syndrome steroidal trial group. Double blind study of intravenous methyl prednisolone in Guillain–Barré syndrome. Lancet. 1993;341(8845):586–590
- Kennard C, Newland AC, Ridley A. Treatment of Guillain–Barré syndrome by plasma exchange. J Neurol Neurosurg Psychiatry. 1982;45:847–850
- The French cooperative group on plasma exchange in Guillain–Barré syndrome. Appropriate number of plasma exchanges in Guillain–Barré syndrome. Ann Neurol. 1997;41:298–306
- The French cooperative group on plasma exchange in Guillain–Barré syndrome. Efficiency of plasma exchange in Guillain–Barré syndrome: role of replacement fluids. Ann Neurol. 1987;22:753–761
- Greenwood RJ, Newsom-Davis J, Hughes RA, et al. Controlled trial of plasma exchange in acute inflammatory polyradiculoneuropathy. Lancet. 1984;1(8382):877–879
- Osterman PO, Lundemo G, Pirskanen R, et al. Beneficial effects of plasma exchange in acute inflammatory polyradiculoneuropathy. Lancet. 1984;324(8415):1296–1299
- Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain–Barré syndrome. Ann Neurol. 1990;27(Suppl):S21–S24
- van der Meché FG, Schmitz PI. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain–Barré syndrome. Dutch Guillain–Barré Study Group. N Engl J Med. 1992;326:1123–1129
- Hughes RA, Swan AV, Raphaël JC, Annane D, van Koningsveld R, van Doorn PA. Immunotherapy for Guillain–Barré syndrome: a systematic review. Brain. 2007;130:2245–2257
- El-Bayoumi MA, El-Refaey AM, Abdelkader AM, El-Assmy MM, Alwakeel AA, El-Tahan HM. Comparison of intravenous immunoglobulin and plasma exchange in treatment of mechanically ventilated children with Guillain–Barré syndrome: a randomized study. Crit Care. 2011;15:R164
- Bril V, Ilse WK, Pearce R, Dhanani A, Sutton D, Kong K. Pilot trial of immunoglobulin versus plasma exchange in patients with Guillain–Barré syndrome. Neurology. 1996;46:100–103
- Randomized trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain–Barré syndrome. Plasma Exchange/Sandoglobulin Guillain–Barré Syndrome Trial Group. Lancet. 1997;349(9047):225–230
- Diener HC, Haupt WF, Kloss TM, et al. A preliminary, randomized, multicenter study comparing intravenous immunoglobulin, plasma exchange, and immune adsorption in Guillain–Barré syndrome. Eur Neurol. 2001;46:107–109
- Nomura T, Hamaguchi K, Hattori T, et al. A randomized controlled trial comparing intravenous immunoglobulin and plasmapheresis in Guillain–Barré syndrome. Neurol Ther. 2000;18:69–81
- Netto AB, Kulkarni GB, Taly AB, Rao GU, Periyavan S, Rao S. A comparison of immunomodulation therapies in mechanically ventilated patients with Guillain–Barré syndrome. J Clin Neurosci. 2012;19:1664–1667
- Ismail N, Neyra R, Hakim RM. Plasmpheresis. In: Daugirdas JT, Blake PG, Ing TS, eds. Handbook of Dialysis. 3rd ed. Phildelphia: LWW; 2001:231–262
- Kaplan AA. A Practical Guide to Therapeutic Plasma Exchange. Malden: Blackwell Sciences; 1999
- Raphael JC, Chevret S, Hughes RA, Annane D. Plasma exchange for Guillain–Barré syndrome. Cochrane Database Syst Rev. 2001;(2):CD001798